Mutz Christopher's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Nov 13, 2023
- Accession no.
- 0001846487-23-000003
- Filed
- Nov 13, 2023
- Trade date
- Nov 10, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $157.4K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mutz ChristopherCIK 0001846487 | Officer (HEAD OF RARE DISEASE) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2023 | Common Stock | SSaleDisposed | −3,000 | $52.47 | −$157,410 | 63,607 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.